QY Research, Inc.

Liposome Drug Delivery Global Market Will Surge at 12.8% CAGR to Hit 6040 Million US$ by 2025: QY Research, Inc

 

Los Angeles, CA -- (SBWIRE) -- 02/02/2019 -- Global Liposome Drug Delivery market report is first of its kind research report that covers the overview, summary, market dynamics, competitive analysis, and leading player's various strategies to sustain in the global market. The Liposome Drug Delivery report covers the five top regions of the globe and countries within, which shows the status of regional development, consisting of market value, volume, size, and price data.  Apart from this, the Liposome Drug Delivery report also covers detail information about various clients which is the most significant element for the manufacturers.

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physicochemical characteristics of the drug substance only.

In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.

North America dominated the market with market share of 42.44% due to the high medical level. Following North America, Europe is the second largest market with market share of 32.33%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 23.81%.

Get PDF report template at https://www.qyresearch.com/sample-form/form/949449/global-liposome-drug-delivery-liposomes-drug-delivery-competition-analysis

The global Liposome Drug Delivery (Liposomes Drug Delivery) market is valued at 2600 million US$ in 2018 is expected to reach 6040 million US$ by the end of 2025, growing at a CAGR of 12.8% during 2019-2025.

This report focuses on Liposome Drug Delivery (Liposomes Drug Delivery) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Liposome Drug Delivery (Liposomes Drug Delivery) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, and Japan.

At the company level, this report focuses on the production capacity, ex-factory price, revenue, and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Gilead Sciences

Pacira

Sun Pharmaceutical

Johnson & Johnson

Luye Pharma

Sigma-Tau Group

Ipsen (Onivyde)

CSPC

Teva Pharmaceutical

Novartis

Fudan-Zhangjiang

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Liposomal Doxorubicin

Liposomal Amphoteracin B

Liposomal Paclitaxel

Others

Segment by Application

Fungal Infection Therapy

Cancer & Tumor Therapy

Others

Get Complete Report in your Inbox within 24 hours  at https://www.qyresearch.com/index/detail/949449/global-liposome-drug-delivery-liposomes-drug-delivery-competition-analysis

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.